COMBINED RESECTION OF THE PANCREAS AND PORTAL-VEIN FOR PANCREATIC-CANCER
COMBINED RESECTION OF THE PANCREAS AND PORTAL-VEIN FOR PANCREATIC-CANCER
复制标题
DOI：
10.1002/bjs.1800810837
复制
发表时间：
1994-08-01
影响因子：
9.6
通讯作者：
TSUZUKI, T
中科院分区：
文献类型：
--
作者：
TAKAHASHI, S;OGATA, Y;TSUZUKI, T
1976年3月至1992年12月，239例胰腺导管细胞癌患者中有137例（57%）接受了切除术; 137例中有79例（58%）接受了胰腺和门静脉联合切除术。79例患者中有63例仅行门静脉切除术，6例死亡（死亡率10%）。死亡率与未行门静脉切除的58例相同。其余16名患者的邻近动脉也被切除，其中7人死亡。在单纯门静脉切除的患者中，4例存活超过5年，占9例5年存活者的近一半。胰腺和门静脉联合切除可提高切除率和改善长期生存率。
Between March 1976 and December 1992, 137 (57 per cent) of 239 patients with pancreatic duct cell cancer underwent resection; 79 (58 per cent) of the 137 had combined resection of the pancreas and portal vein. Sixty-three of the 79 patients underwent resection of the portal vein alone; six died (mortality rate 10 per cent). The mortality rate was the same as that in 58 patients with no resection of the portal vein. In the remaining 16 patients adjacent arteries were also resected, with seven deaths. Of patients with resection of the portal vein alone who underwent curative resection, four survived more than 5 years, accounting for nearly half of the nine 5-year survivors. Combined resection of the pancreas and portal vein is associated with both an increased resectability rate and improved long-term survival.